EI
Insider
Edward J Dulac III
EVP, Chief Financial OfficerEdward J Dulac III (EVP, Chief Financial Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Intellia Therapeutics, Inc. (NTLA). The largest single filing was $105K of NTLA (7,462 sh × $14.02, as filed), executed Jul 23 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$105K
shares × price, as filed
Last traded
Jul 23 2025
Filed Jul 25 2025
Median ADV $62.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $105K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NTLARecent filings
NTLASALE
Intellia Therapeutics, Inc.
View filing →
$105K7,462 sh × $14.02
Exec Jul 23 2025
Filed Jul 25 2025 · 5:30 PM ET